While Aβ burden is directly correlated with dementia severity and anti-correlated with zinc levels and clearance in AD patients [93,94], future studies will be required in human AD brains and mouse models to assess whether this is due to decreased GPR39 activity and whether restoring or increasing GPR39 activity can restore homeostasis and slow AD progression. The gene discussed is GPR39; the disease is Alzheimer disease.